Pancreatic neuroendocrine tumor (pNET), well-differentiated G1/G2 · None

Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.

Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.

Source YAML: complete record

Track	standard
Linked regimen	`None`

ID	`IND-MEN1-CARRIER-SURVEILLANCE`
Type	Indication
Status	reviewed 2026-05-18 \| pending_clinical_signoff
Diseases	`DIS-PNET`
Sources	`SRC-NCCN-BCELL-2025` `SRC-NCCN-NET-2025`

Notes

STUB — v0.2-B confirmed-carrier surveillance pathway (MEN1). Two-Clinical-Co-Lead signoff queued. Sibling — IND-MEN1-CARRIER-INTENSIFIED (aggressive plan_track).

Used By

Actionability

BMA-CHROMOGRANIN-A-NET-MEN1-SURVEILLANCE - Chromogranin A (CgA) is a granin-family secretory protein expressed ubiquitously in neuro...

Algorithms

ALGO-MEN1-CARRIER-SURVEILLANCE - ALGO-MEN1-CARRIER-SURVEILLANCE

Indication

IND-MEN1-CARRIER-INTENSIFIED - IND-MEN1-CARRIER-INTENSIFIED

Red flag

RF-MEN1-CONFIRMED-CARRIER - Confirmed germline pathogenic / likely-pathogenic variant in the MEN1 (menin) gene. Patie...
RF-MEN1-FAMILY-HISTORY-SUSPICION - Family pedigree suggestive of Multiple Endocrine Neoplasia type 1 (MEN1, Wermer syndrome)...